Research Peptide Comparison
Retatrutide 20mg and Tirzepatide Pen 60mg are both GLP-1 Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
Retatrutide is a synthetic peptide acting as a triple agonist of the GLP-1, GIP and glucagon receptors, combining two incretin pathways with concurrent glucagon receptor engagement. This unique pharmacological profile has positioned it as a key reference compound in research into glucose handling, adiposity and whole-body energy balance, and one of the most-studied triple agonists in modern metabolic research.
Compared to Tirzepatide Pen 60mg, Retatrutide 20mg is priced at £124.50 with 99%+ verified purity. Its CAS registry number is 2381089-83-2. It has a molecular weight of 4875.42 g/mol.
Retatrutide 20mg is available in 10mg, 20mg, 40mg and ships with a full Certificate of Analysis from Janoshik Analytical. At £75.50 less than Tirzepatide Pen 60mg, it is the more affordable option in this comparison.
Tirzepatide is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. By activating both incretin pathways simultaneously, it has become one of the most-studied molecules in modern metabolic and obesity research.
Compared to Retatrutide 20mg, Tirzepatide Pen 60mg is priced at £200.00 with 99.5%+ verified purity. Its CAS registry number is 2023788-19-2. It has a molecular weight of 4813.52 g/mol.
Tirzepatide Pen 60mg is available in 30mg, 60mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £75.50 higher than Retatrutide 20mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
